ALFA Filings
Every announcement, straight from the exchange
Every SMS Pharmaceuticals results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
SMS Pharmaceuticals released a press release on its Q2 and H1 FY27 results, showing strong growth. Management now expects FY27 revenue growth and EBITDA margins above earlier guidance.
SMS Pharmaceuticals reported Q1FY27 revenue of ₹207 crore, up 6% YoY. The board also approved a ₹50 crore loan infusion into its subsidiary, SMS Peptides.
SMS Pharmaceuticals reported FY26 revenue of ₹886.87 Crore, a 13% YoY increase. Net profit surged 47% to ₹101.98 Crore, driven by backward integration and mix.